Encephalitis411’s medical faculty brings an amazing depth of experience with encephalitis, collectively affiliated with the care of more than 6,000 patients. Their knowledge includes both adult and pediatrics and infectious and auto-immune encephalitis. They have contributed to numerous research studies on encephalitis cases, emerging technology in studying encephalitis, and the benefits or risks of different vaccinations. If there was a “Who’s Who” of encephalitis, we are privileged that these physicians have devoted their time to working with Encephalitis411.
Dr. Karen Bloch
She has been an investigator on several Emerging Infections Program (EIP) studies sponsored by the CDC.
She has been awarded the William Schaffner Teaching award in infectious diseases in 2003, 2008, and 2011.
She has contributed to the Infectious Diseases Society of America guidelines on the management of encephalitis (2008) and co-authored the International Encephalitis Consortium recommendations on the case definition for encephalitis (2013).
Dr. Bloch graduated from medical school at the University of Virginia (MD, 1990).
She completed internship and residency at Yale-New Haven Hospital (New Haven, CT) in 1993, and infectious disease fellowship at the University of California, San Francisco (UCSF) in 1997.
She received her Master’s in Public Health (MPH) from the University of California, Berkeley in 1996.
She is board certified in Infectious Diseases.
Dr. Carol Glaser
Dr. Carol Glaser, DVM, MPVM, MD is currently a pediatric infectious disease physician at the Kaiser Oakland Medical Center in California and serves as a voluntary faculty member at the University of California San Francisco as well. Dr. Glaser first trained in veterinary medicine at the UC Davis Veterinary School and then attended Medical School at Tulane Medical School followed by a pediatric residency and pediatric infectious disease fellowship at the University of California, San Francisco (UCSF).
Prior to joining Kaiser Permanente, she worked at the California State Public Health Department (CDPH) for 20 years. The first part of her tenure at CDPH was as Medical Officer and then Chief of the Viral Rickettsia Disease Laboratory (VRDL). Working with the VRDL, she set up several different syndromic surveillance projects. She initiated the California Encephalitis Project (CEP) and served as the Principal Investigator for 15 years. While at CDPH VRDL, she was also involved in syndromic surveillance for severe unexplained respiratory illnesses and severe febrile rash illnesses in pediatrics (for CAV-6 enterovirus) as well as unexplained deaths. She also served as Interim Chief of the CDPH Immunization Branch and worked with many issues related to vaccine-preventable diseases including measles and pertussis outbreaks.
Most recently she was involved in the state-wide investigation of the acute flaccid paralysis syndrome in California.
She has over 50 peer-reviewed publications; most of which are related to neurologic infectious diseases, zoonotic infections or vaccine preventable diseases. She has authored several chapters on neurologic infections and zoonotic infections.
At Kaiser Permanente, she leads the newly formed Pediatric Antimicrobial Stewardship program.
Dr. Allan Tunkel
He has received numerous teaching awards and honors and is passionate about physician training and mentorship. An undergraduate of Seton Hall University, Dr. Tunkel later pursued a PhD in experimental pathology followed by a medical degree at the University of Medicine and Dentistry of New Jersey, New Jersey Medical School. He completed his residency and chief residency in Medicine at the Hospital of the Medical College of Pennsylvania followed by a fellowship in Infectious Diseases at the University of Virginia. He is widely acknowledged as an international expert in bacterial meningitis and other central nervous system infections.
Dr. Arun Venkatesan
Dr. Venkatesan specializes in immunological/inflammatory and infectious diseases that affect the nervous system.
As Director of the Johns Hopkins Encephalitis Center, he oversees clinical activities and research, and has developed a multidisciplinary program devoted to delineating pathogenesis and optimizing diagnosis and management of autoimmune and infectious conditions that affect the central nervous system.
Dr. Venkatesan received his Ph.D. in microbiology/immunology and his M.D. from the University of California, Los Angeles, followed by an internship in internal medicine at Santa Clara Valley Medical Center.
He completed his residency in neurology at The Johns Hopkins Hospital.
He has received funding from the National Institutes of Health, Howard Hughes Medical Institute, National Multiple Sclerosis Society, and Maryland Stem Cell Research Fund.
Dr. Michael Wilson
Dr. Michael Wilson is a neurologist specializing in infectious and autoimmune diseases of the central nervous system at the University of California at San Francisco (UCSF) Weill Institute for Neurosciences. Dr. Wilson has contributed to more than 60 research papers, with many focusing on emerging diagnostic and therapeutic tools for meningitis, encephalitis and multiple sclerosis. He completed his residency in neurology and fellowship in Neuro-Infectious diseases at Massachusetts General Hospital. He got a postdoctoral fellowship in metagenomics and virology at UCSF, Boston University and the National Emerging Infectious Diseases Laboratories. Dr. Wilson has received several awards, including the Award in Neuroscience from the American Neurological Association-Grass Foundation and the Debbie and Andy Rachleff Distinguished Professorship in Neurology from UCSF. His patient base includes people with autoimmune diseases like multiple sclerosis and autoimmune encephalitis as well as patients with a wide array of infectious diseases that impact the nervous system like HIV, neurocysticercosis, neurosyphilis, viral encephalitis and fungal infections. His laboratory applies metagenomic and immune repertoire sequencing techniques as well as phage display antibody discovery technologies to enhance our understanding of the causes and immunopathogenesis of multiple sclerosis as well as autoimmune and infectious causes of meningoencephalitis.